Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Lexaria Bioscience Corp. (LEXXW)

0.0012 -0.0038 (-76.00%)
At close: January 13 at 3:20:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
8/31/2025
8/31/2024
8/31/2023
8/31/2022
Total Revenue
194
705.9230
464.2780
226.2080
255.3970
Cost of Revenue
0
2.7200
4.8220
31.5000
71.8410
Gross Profit
194
703.2030
459.4560
194.7080
183.5560
Operating Expense
7,901.9350
12,583.9400
6,212.5860
6,728.7300
6,802.5950
Operating Income
-7,707.9350
-11,880.7370
-5,753.1300
-6,534.0220
-6,619.0390
Net Non Operating Interest Income Expense
5.4340
3.0170
14.3110
43.1900
0
Other Income Expense
-33.5400
-33.7140
-69.8350
-221.6930
-764.6140
Pretax Income
-7,736.0410
-11,911.4340
-5,808.6540
-6,712.5250
-7,383.6530
Net Income Common Stockholders
-7,732.0260
-11,901.8410
-5,795.3450
-6,664.8990
-7,269.3240
Diluted NI Available to Com Stockholders
-7,732.0260
-11,901.8410
-5,795.3450
-6,664.8990
-7,269.3240
Total Operating Income as Reported
-7,707.9350
-11,880.7370
-5,753.1300
-6,534.0220
-6,619.0390
Total Expenses
7,901.9350
12,586.6600
6,217.4080
6,760.2300
6,874.4360
Net Income from Continuing & Discontinued Operation
-7,732.0260
-11,901.8410
-5,795.3450
-6,664.8990
-7,269.3240
Normalized Income
-7,698.4860
-11,868.1270
-5,725.5100
-6,443.2060
-6,504.7100
Interest Income
5.4340
3.0170
14.3110
43.1900
0
Net Interest Income
5.4340
3.0170
14.3110
43.1900
0
EBIT
-7,707.9350
-11,880.7370
-5,753.1300
-6,534.0220
-6,619.0390
EBITDA
-7,631.3620
-11,792.9120
-5,676.9770
-6,388.6250
-6,516.3210
Reconciled Cost of Revenue
0
2.7200
4.8220
31.5000
71.8410
Reconciled Depreciation
76.5730
87.8250
76.1530
145.3970
102.7180
Net Income from Continuing Operation Net Minority Interest
-7,732.0260
-11,901.8410
-5,795.3450
-6,664.8990
-7,269.3240
Total Unusual Items Excluding Goodwill
-33.5400
-33.7140
-69.8350
-221.6930
-764.6140
Total Unusual Items
-33.5400
-33.7140
-69.8350
-221.6930
-764.6140
Normalized EBITDA
-7,597.8220
-11,759.1980
-5,607.1420
-6,166.9320
-5,751.7070
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: